Edwards-JenaValve injunction would serve public interest most, US judge says
Despite arguments from Edwards Lifesciences and JenaValve that their merger is in the interest of American patients, US judge Rudolph Contreras sided with the US Federal Trade Commission that the companies...To view the full article, register now.
Already a subscriber? Click here to view full article